H Piguet
About
In The Last Decade
H Piguet
31 papers receiving 1.6k citations
Hit Papers
Peers
Comparison fields: 5 of 66
- Genetics 1.4k
- Pathology and Forensic Medicine 1.2k
- Immunology 685
- Hematology 307
- Oncology 258
Countries citing papers authored by H Piguet
This map shows the geographic impact of H Piguet's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H Piguet with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H Piguet more than expected).
Fields of papers citing papers by H Piguet
This network shows the impact of papers produced by H Piguet. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H Piguet. The network helps show where H Piguet may publish in the future.
Co-authorship network of co-authors of H Piguet
This figure shows the co-authorship network connecting the top 25 collaborators of H Piguet. A scholar is included among the top collaborators of H Piguet based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H Piguet. H Piguet is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | [True primary erythroblastopenia in the adult]. | 0 |
| 2 | 21 | |
| 3 | 18 | |
| 4 | Residual disease in B-cell chronic lymphocytic leukemia patients and prognostic value. | 22 |
| 5 | 12 | |
| 6 | [Production of hyaluronan-binding glycoprotein by human monocytes. Its use as marker in myeloid leukemia]. | 2 |
| 7 | Rearrangements of immunoglobulin light and heavy chain genes and correlation with phenotypic markers in B-cell chronic lymphocytic leukemia. | 8 |
| 8 | 9 | |
| 9 | 17 | |
| 10 | [Splenectomy in chronic idiopathic thrombopenic purpura in adults. Apropos of 49 cases]. | 3 |
| 11 | 4 | |
| 12 | [Preventive treatment of infection caused by gram-negative bacteria using anti-lipopolysaccharide antibodies. Evaluation in patients with aplasia]. | 4 |
| 13 | 21 | |
| 14 | [First-line treatment of febrile episodes in leukemia in adults. Randomized, multicenter study of ceftazidime in single antibiotic therapy versus a cefotaxime-amikacin combination]. | 3 |
| 15 | 4 | |
| 16 | [Spontaneous remission of refractory anemia with excess of blasts after septicemia]. | 1 |
| 17 | 1 | |
| 18 | 28 | |
| 19 | A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis breakdown → | 1282 |
| 20 | [Arteriovenous fistulas occupying the splenic pedicle]. | 1 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.